t-PA activity and antigen in thrombolytic treatment with rt-PA in children

被引：0
|
作者：
RisseeuwAppel, IM
Dekker, I
Stigter, RL
vanKesselBakvis, CL
机构：
来源：
FIBRINOLYSIS | 1996年 / 10卷
关键词：
D O I：
10.1016/S0268-9499(96)80050-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The effect of increasing doses of rt-PA (Alteplase) in catheter related thrombi in children was studied. The data suggest that optimal local fibrinolytic treatment is realized at a systemic level of 0.80 ng/ml of t-PA, which was reached with a dosis of 0.10 mg/kg hour directly infused via the affected catheter. After the introduction of rt-PA the level of PAI-1 activity immediately fell below 2 IU/ml, whereas the amount of PAI-1 antigen stayed at the same level throughout rt-PA treatment.
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [41] Temperature Affects Thrombolytic Efficacy Using rt-PA and Eptifibatide, an In Vitro Study
    Meunier, Jason M.
    Chang, Wan-Tsu W.
    Bluett, Brent
    Wenker, Evan
    Lindsell, Christopher J.
    Shaw, George J.
    THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT, 2012, 2 (03) : 112 - 118
  • [42] In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA
    Fruehwald, Tobias
    Gaertner, Ulrich
    Stoeckmann, Nils
    Marxsen, Jan-Henning
    Gramsch, Carolin
    Roessler, Florian C.
    BMC NEUROLOGY, 2019, 19 (01)
  • [43] Clinical deterioration following intravenous rt-PA treatment
    Saqqur, M
    Molina, CA
    Siddiqui, MM
    Ribo, M
    Uchino, K
    Calleja, S
    Garami, Z
    Akhtar, N
    Salam, A
    Shuaib, A
    Rizvi, N
    Khan, K
    Demchuk, AM
    Alexandrov, AV
    STROKE, 2006, 37 (02) : 704 - 704
  • [44] Recurrent rate of stroke after rt-PA treatment
    Tiamkao, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1112 - 1112
  • [45] Extra-fibrinolytic beneficial effects of treatment with rt-PA in Stroke: Impact of rt-PA in serum BDNF levels.
    Rodier, M.
    Bejot, Y.
    Jacquin, A.
    Marie, C.
    Garnier, P.
    CEREBROVASCULAR DISEASES, 2014, 37 : 330 - 330
  • [46] Misleading conclusions on rt-PA treatment in the very elderly
    Vroomen, PCAJ
    Uyttenbogaart, M
    Luijckv, GJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (06): : 799 - 799
  • [47] Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke
    Orset, Cyrille
    Arkelius, Kajsa
    Anfray, Antoine
    Warfvinge, Karin
    Vivien, Denis
    Ansar, Saema
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke
    Cyrille Orset
    Kajsa Arkelius
    Antoine Anfray
    Karin Warfvinge
    Denis Vivien
    Saema Ansar
    Scientific Reports, 11
  • [49] EMBOLIC OCCLUSION OF THE MIDDLE AND INTERNAL CAROTIDE ARTERY. EMERGENT TREATMENT WITH RT-PA THROMBOLYTIC AGENT
    Limuris, A.
    Fistas, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 156 - 156
  • [50] NIHSS-Time Score Predicts Outcomes in rt-PA Patients: SAMURAI rt-PA Registry
    Aoki, Junya
    Kimura, Kazumi
    Koga, Masatoshi
    Kario, Kazuomi
    Nakagawara, Jyoji
    Furui, Eisuke
    Shiokawa, Yoshiaki
    Hasegawa, Yasuhiro
    Okuda, Satoshi
    Yamagami, Hiroshi
    Okada, Yasushi
    Shibazaki, Kensaku
    Sakamoto, Yuki
    Toyoda, Kazunori
    CEREBROVASCULAR DISEASES, 2012, 34 : 52 - 53
12345